EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Membrane-Coated Iron Oxide (Fe3O4) Nanoparticles Encapsulating Dacarbazine Suppress B16F10 Melanoma Cell Activity in vitro and in a Subcutaneous Mouse Model

Hao Ding, Dan Li Li, Zi Yi Zhou, Xiang Dong Lai, Nan Yang, Liu Chang Tan, Yuan Gang Lu

International Journal of Nanomedicine · 2026

DOI: 10.2147/ijn.s635477 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2026. Verfasst von Hao Ding und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic & Cosmetic Surgery, Daping Hospital Army Medical University, Chongqing, 400042, People's Republic of China. Hauptthemen laut MEDLINE: Dacarbazine, Melanoma, Experimental, Magnetic Iron Oxide Nanoparticles, Magnetite Nanoparticles. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Malignant melanoma is a highly aggressive skin cancer. Dacarbazine (DTIC) chemotherapy, while historically used, is limited by poor solubility, short half-life, and systemic toxicity. Fe3O4 nanoparticles have been explored as drug delivery vectors with potential for photothermal conversion and Fenton-like catalytic activity. Cell membrane-camouflaged platforms may offer improved tumor targeting.

Methods

A biomimetic nanoplatform (Fe3O4PD@CCM) was engineered by encapsulating an Fe3O4 core within a DTIC-loaded PLGA-PEG2000 matrix, followed by functionalization with B16F10 cancer cell membranes. Physicochemical properties were characterized by dynamic light scattering (DLS), scanning electron microscopy (SEM), and liquid chromatography-mass spectrometry (LC-MS). Antitumor effects were assessed in B16F10 melanoma cells and in a subcutaneous syngeneic mouse model (n=4 per group).

Results

Fe3O4PD@CCM Nanoparticles (NPs) exhibited a hydrodynamic diameter of ~25-30 nm, sustained DTIC release, and retention of membrane proteins. In vitro, the Fe3O4PD@CCM + NIR (Near-infrared irradiation) group showed reduced cell viability, increased apoptosis, G2/M phase arrest, and elevated intracellular reactive oxygen species (ROS) levels compared to controls. In vivo, Cy5-labeled Fe3O4PD@CCM NPs showed preferential fluorescence accumulation in tumors relative to non-coated NPs, with whole-body fluorescence diminishing within 24 h. In a 12-day efficacy study, Fe3O4PD@CCM + NIR treatment was associated with reduced tumor growth compared to control groups. Acute biosafety assessment at 24 h post-injection of a single high dose (200 mg/kg) revealed no overt abnormalities in the evaluated hematological, biochemical, or histopathological parameters.

Conclusion

Fe3O4PD@CCM NPs combined with NIR suppressed B16F10 cell activity in vitro and subcutaneous tumor growth in a preliminary mouse model. These findings represent a proof-of-concept demonstration. Further studies-including detailed mechanistic validation, long-term toxicity assessment, and evaluation in more clinically relevant models-are required to assess the translational potential of this platform.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DacarbazineMelanoma, ExperimentalMagnetic Iron Oxide NanoparticlesMagnetite NanoparticlesAntineoplastic AgentsAnimalsMiceCell Line, TumorMice, Inbred C57BLCell SurvivalReactive Oxygen SpeciesAntineoplastic Agents, Alkylating

Stichwörter der Autor:innen

dacarbazineiron oxide nanoparticlesmalignant melanomanear-infrared irradiation

Substanzen

DacarbazineReactive Oxygen SpeciesMagnetite NanoparticlesAntineoplastic AgentsAntineoplastic Agents, Alkylating

Autor:innen und Institutionen

  • Department of Plastic & Cosmetic Surgery, Daping Hospital Army Medical University, Chongqing, 400042, People's Republic of China.

Zitieren

APA

Ding, H., Li, D. L., Zhou, Z. Y., Lai, X. D., Yang, N., Tan, L. C., & Lu, Y. G. (2026). Membrane-Coated Iron Oxide (Fe3O4) Nanoparticles Encapsulating Dacarbazine Suppress B16F10 Melanoma Cell Activity in vitro and in a Subcutaneous Mouse Model. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s635477

Vancouver

Ding H, Li DL, Zhou ZY, Lai XD, Yang N, Tan LC, et al. Membrane-Coated Iron Oxide (Fe3O4) Nanoparticles Encapsulating Dacarbazine Suppress B16F10 Melanoma Cell Activity in vitro and in a Subcutaneous Mouse Model. International Journal of Nanomedicine. 2026. doi:10.2147/ijn.s635477

BibTeX
@article{Ding2026,
  author = {Ding, Hao and Li, Dan Li and Zhou, Zi Yi and Lai, Xiang Dong and Yang, Nan and Tan, Liu Chang and Lu, Yuan Gang},
  title = {Membrane-Coated Iron Oxide (Fe3O4) Nanoparticles Encapsulating Dacarbazine Suppress B16F10 Melanoma Cell Activity in vitro and in a Subcutaneous Mouse Model},
  journal = {International Journal of Nanomedicine},
  year = {2026},
  doi = {10.2147/ijn.s635477}
}
Kostenlos starten →